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Ethnopharmacological  relevance:  Cymbopogon  citratus  (DC)  Stapf  (Poaceae-Gramineae),  an  herb com-
monly  known  as  lemongrass  (LG),  is  an important  source  of  ethnomedicines  as well  as  citral,  the major
constituent  of Cymbopogon  citratus,  used  in perfumery,  cosmetic  and  pharmaceutical  industries  for  con-
trolling  pathogens.  Thus,  the goal of this  work  was  to analyze  the  effect  of  LG and  citral  on cytokines
production  (IL-1,  IL-6  and  IL-10)  in vitro,  as well  as  before  or after  LPS  incubation.
Materials and  methods:  Peritoneal  macrophages  from  BALB/c  mice  were  treated  with  LG or citral  in
different  concentrations  for 24 h. The  concentrations  that  inhibited  cytokines  production  were  tested
before  or  after  macrophages  challenge  with  LPS,  in  order  to  evaluate  a  possible  anti-inﬂammatory  action.
Supernatants  of  cell  cultures  were  used  for cytokines  determination  by ELISA.
Results:  As  to  IL-1,  only  citral inhibited  its release,  exerting  an efﬁcient  action  before  LPS challenge.  LG
and  citral  inhibited  IL-6  release.  Cymbopogon  citratus  showed  inhibitory  effects  only  after  LPS  challenge,
whereas  citral  prevented  efﬁciently  LPS  effects  before  and  after  LPS  addition.  Citral  inhibited  IL-10  pro-
duction  and  although  LG  did  not  inhibit  its  production,  the  concentration  of 100  g/well  was  tested  in the
LPS-challenge  protocol,  because  it  inhibited  IL-6  production.  LG inhibited  LPS action  after  macrophages
incubation  with LPS, while  citral  counteracted  LPS  action  when  added  before  or after  LPS  incubation.
Conclusion:  LG  exerted  an  anti-inﬂammatory  action  and  citral  may  be involved  in its inhibitory  effects
on  cytokines  production.  We  suggest  that  a  possible  mechanism  involved  in such  results  could  be the
tion  inhibition  of the transcrip
. Introduction
Cymbopogon citratus (DC) Stapf (Poaceae-Gramineae), an herb
ommonly known as lemongrass (LG), is an important source of
thnomedicines. The tea from its leaves has been widely used as an
ntiseptic, antifever, antidyspeptic, carminative, tranquilizer and
tomachic agent (Barbosa et al., 2008). Several studies have also
emonstrated the anti-inﬂammatory, antiseptic, diuretic, neuro-
ehavioral, antimicrobial, and fungistatic activities of Cymbopogon
itratus (Carbajal et al., 1989; Francisco et al., 2011). Citral (3,7-
imethyl-2,6-octadienal) is the major constituent of Cymbopogon
itratus and has been used in perfumery, cosmetic and pharmaceu-
ical industries for controlling pathogens (Guynot et al., 2003).
Macrophages are one of the ﬁrst lines of host defense. These cells
ndergo a series of physiological changes in response to infections
r exposure to pathogen-derived products such as lipopolysac-
haride (LPS). Upon activation, macrophages are more adept to
ill pathogens. These cells are an important source of inﬂam-
atory cytokines, which represent an important strategy of host
efense (Cao et al., 2006). As an example, interleukin (IL)-1, a pro-
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inﬂammatory cytokine, is a key mediator of inﬂammation, inducing
fever and the acute-phase response. IL-1 has important functions
in the innate immune defense against microbes, trauma and stress,
and is also an effector molecule involved in tissue destruction and
ﬁbrosis (Mandrup-Poulsen et al., 2010).
IL-6 is a potent and pleiotropic regulatory cytokine that medi-
ates a plethora of physiological functions. IL-6 is known to
inﬂuence cell growth, differentiation and migration during immune
responses, hematopoiesis and inﬂammation (Frick et al., 2010).
Overproduction of proinﬂammatory cytokines may cause
immunopathologies while defective production of these cytokines
results in uncontrolled infection. Macrophages may  control the
overproduction of pro-inﬂammatory cytokines by producing
anti-inﬂammatory cytokines such as IL-10, since it can inhibit
the transcription and translation of a variety of inﬂammatory
cytokines, reduce antigen presentation and inhibit or bias T cell
activation (Anderson and Mosser, 2002).
Several studies have reported the traditional use of Cymbopogon
citratus, but little is known about their inﬂuence on the immune
system. In a previous work we  reported that the treatment of
Open access under the Elsevier OA license. mice with LG water extract inhibited macrophages to produce IL-
1 and IL-6 production, suggesting the anti-inﬂammatory action
of this spice in vivo (Sforcin et al., 2009). Thus, this study aimed
to investigate the potential immunomodulatory effect of Cymbo-
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2.5.1. Lemongrass and citral incubation before LPS challenge
Macrophages were pre-treated with LG (100 g/well) or citral
(25, 50 and 100 g/well for IL-1; 5, 10, 25, 50 and 100 g/well for
IL-6 and IL-10) at the concentrations that inhibited IL-1, IL-6 and
Co
ntr
ol [5] [10
]
[25
]
[50
]
[10
0]
0
100
200
300
400
*
*
Lemongrass
 IL
-1
β (
pg
/m
L)
Co
ntr
ol [5] [10
]
[25
]
[50
]
[10
0]
0
100
200
300
*
*
 **
Citral
IL
-1
β 
(p
g/
m
L)
co
ntr
ol
C [
25
] +
 LP
S
C [
50
] +
 LP
S
C [
10
0] 
+ L
PS
LP
S +
 C 
[25
]
LP
S +
 C 
[50
]
LP
S +
 C 
[10
0]
DE
X
LP
S
0
500
1000
1500
***
***
*** *** ***
 IL
-1
β (
pg
/m
L)
B
C
A
Fig. 1. IL-1 production (pg/mL) by peritoneal macrophages incubated with (A)
lemongrass (LG) or (B) citral (C) at different concentrations (5, 10, 25, 50 and
100 g/well) for 24 h at 37 ◦C. (C) IL-1 production by peritoneal macrophages stim-10 T.F. Bachiega, J.M. Sforcin / Journal o
ogon citratus on cytokines production (IL-6, IL-1 and IL-10) by
eritoneal macrophages in vitro. After, the concentrations of Cym-
opogon citratus that inhibited cytokines production were tested
efore or after macrophages challenge with LPS. Citral effects were
lso evaluated, in order to investigate a possible compound respon-
ible for Cymbopogon citratus action.
. Materials and methods
.1. Lemongrass extract
The aerial parts of Cymbopogon citratus were collected in the
ageado Experimental Farm, UNESP, Campus of Botucatu. The plant
aterial was identiﬁed and a voucher specimen (BOTU 25663) was
tored in the Herbarium Botu of the Department of Botany, UNESP,
ampus of Botucatu.
Fresh plant material was air-dried at 40 ◦C for 48 h. The dried
eaves (400.0 g) were powdered in a blender and submitted to
aceration for 72 h in 4 L of aqueous methanol 70% (v/v) at room
emperature. The macerated material was ﬁltered and concen-
rated in rotaevaporator. This dried extract was lyophilized and
peciﬁc dilutions were prepared in RPMI media for each assay.
.2. Citral
Citral was kindly provided by Dr. Jairo K. Bastos, School of Phar-
aceutical Sciences of Ribeirão Preto, USP, Brazil. Speciﬁc dilutions
f citral were prepared in RPMI media for the experiments.
.3. Animals and peritoneal macrophages
Male BALB/c mice weighing 25–30 g and aged between 8 and
2 weeks were used. Mice were kept in rooms at 21–25 ◦C and 50%
elative humidity, with a 12 h light/dark cycle. Food and water were
rovided ad libitum.
Peritoneal macrophages were obtained by inoculation of 3–5 mL
f cold PBS in abdominal cavity. After a soft abdominal massage
or 30 s, the peritoneal liquid was collected and put in sterile plas-
ic tubes (Falcon). This procedure was repeated 3 or 4 times for
ach animal and the tubes were centrifuged at 200 × g for 10 min.
ells were stained with neutral red (0.02%), incubated for 10 min  at
7 ◦C and counted in a haematocytometer to obtain a ﬁnal concen-
ration of 2 × 106 cells/mL. Cells were resuspended in cell culture
edium (RPMI 1640, supplemented with 10% fetal calf serum,
 mM l-glutamine, 20 mM HEPES – Sigma, USA) and cultured in
 96-well ﬂat-bottomed plate (Corning, USA) at a ﬁnal concentra-
ion of 2 × 105 cells per well. Cells were incubated at 37 ◦C and, after
 h, non-adherent cells were removed (Sforcin, 2007).
This work agrees with the Ethical Principles in Animal Research
dopted by the Brazilian College of Animal Experimentation, and
as approved in August 8, 2008 (protocol n◦ 46/08-CEEA).
.4. Cytotoxicity assay
Prior to in vitro assays, cells were incubated with LG extract or
itral at the concentrations 5, 10, 25, 50 and 100 g/well, in order
o carry out the assays only with noncytotoxic concentrations. The
valuation of cytotoxicity was carried out by crystal violet method
Ait-Mbarek et al., 2007).
The macrophage culture received the stimuli as previously
escribed, and after 24 h, supernatants were removed and 100 L
.5% crystal violet solution was added to the cells. After 10 min  incu-
ation at room temperature, the plates were washed and viable
rystal violet-stained cells were lysed with 1% sodium dodecyl
ulphate. Optical densities (OD) were read at 492 nm in an ELISA
eader, and the percentage of cell viability was calculated usingpharmacology 137 (2011) 909– 913
the formula: [OD test/OD control] × 100. Assays were carried out
in triplicate.
2.5. In vitro assays
Macrophages were incubated with LG or citral at different con-
centrations (5, 10, 25, 50 and 100 g/well) for 24 h, supernatants
were harvested and stored at −70 ◦C for cytokines (IL-1, IL-6 and
IL-10) measurement. Concentrations that inhibited IL-1 and IL-6
production followed two  other protocols, challenging the cells with
LPS.ulated with LPS 2 h before or after incubation with C (25, 50 and 100 g/well) for
22  h. DEX (10−4 mol/L) and LPS (5 g/mL) were used as negative and positive control,
respectively. *Signiﬁcantly different from control (P < 0.01); **signiﬁcantly different
from control (P < 0.001); ***signiﬁcantly different from LPS (P < 0.0001). Data are
expressed as means ± standard-deviation of 5–7 similar assays.
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Fig. 2. (A) IL-6 production (pg/mL) by peritoneal macrophages incubated with lemongrass (LG) or citral (C) at different concentrations (5, 10, 25, 50 and 100 g/well) for
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2  h. DEX (10−4 mol/L) and LPS (5 g/mL) were used as negative and positive contr
rom  control or LPS (P < 0.0001). Data are expressed as means ± standard-deviation
L-10 production for 2 h and then incubated with LPS (5 g/mL) for
2 h. After this period, the culture supernatants were harvested and
tored at −70 ◦C for cytokines measurement (Shin et al., 2006).
.5.2. Lemongrass and citral incubation after LPS challenge
Macrophages were stimulated with LPS (5 g/mL) for 2 h
nd then incubated with LG (100 g/well) or citral (25, 50 and
00 g/well for IL-1; 5, 10, 25, 50 and 100 g/well for IL-6 and
L-10) for 22 h. Afterwards, supernatants were collected and stored
t −70 ◦C for cytokines determination (Shin et al., 2006).
Dexamethasone (DEX, 10−4 mol/L) (Zhuo et al., 2010) and LPS
5 g/mL) were used as a negative and positive control, in order to
nhibit and stimulate cytokine production, respectively.
.6. Determination of cytokine production
IL-1, IL-6 and IL-10 production was measured by enzyme-
inked immunosorbent assay (ELISA), according to manufacturer’s
nstructions (BD Biosciences, USA). Brieﬂy, a 96-well ﬂat bottom
unc Maxisorp (Nunc/Apogent, USA) was coated with a capture
ntibody speciﬁc to each cytokine. The plate was washed and
locked before 100 L of the supernatants and serially diluted spe-
iﬁc standards were added to the respective wells. Following a
eries of washing, the captured cytokine was detected using the
peciﬁc conjugated detection antibody. The substrate reagent was
dded into each well and, after color development, the plate was
ead at 450 nm,  using an ELISA plate reader (Tan et al., 2006)..7. Statistical analysis
Data were expressed as means ± standard-deviation of 5–7 sim-
lar assays. Analysis of variance (ANOVA) was used, followed bye or after incubation with LG (100 g/well) and C (5, 10, 25, 50 and 100 g/well) for
pectively. *Signiﬁcantly different from control (P < 0.001); **signiﬁcantly different
 similar assays.
Dunnet’s multiple comparison method, with 0.05 was chosen as
the signiﬁcant level (Zar, 1999).
3. Results
3.1. Cytotoxicity assay
Cymbopogon citratus extract and citral did not affect cell viability
as determined by crystal-violet test (data not shown).
3.2. Cytokines production
3.2.1. IL-1  ˇ production
As to IL-1, Cymbopogon citratus (5 and 10 g/well) stimulated
signiﬁcantly its production (P < 0.01), whereas the concentrations
25, 50 and 100 g/well did not affect its production (P > 0.05)
(Fig. 1A). Citral (5 g/well) stimulated this cytokine production
(P < 0.001), whereas 10 and 25 g/well did not affect its production
(P > 0.05) and 50 and 100 g/well inhibited signiﬁcantly its release
(P < 0.01) (Fig. 1B).
Thus, in the next protocol, since citral exerted an inhibitory
action in IL-1 production (50 and 100 g/well), macrophages were
challenged with LPS before or after incubation with citral. The con-
centration of 25 g/well was  also included in this assay, since it
diminished IL-1 production, although non-signiﬁcantly. As seen
in Fig. 1C, citral prevented LPS action, exerting an efﬁcient action
before LPS challenge (P < 0.0001). Cymbopogon citratus extract was
not evaluated in LPS-challenge assays since it did not inhibit IL-1
production.3.2.2. IL-6 production
IL-6 production was signiﬁcantly (P < 0.0001) increased after
Cymbopogon citratus incubation for 24 h (5, 10, 25 and 50 g/well),
912 T.F. Bachiega, J.M. Sforcin / Journal of Ethnopharmacology 137 (2011) 909– 913
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Fig. 3. (A) IL-10 production (pg/mL) by peritoneal macrophages incubated with lemongrass (LG) or citral (C) at different concentrations (5, 10, 25, 50 and 100 g/well) for
24  h at 37 ◦C. (B) IL-10 production by peritoneal macrophages stimulated with LPS 2 h before or after incubation with LG (100 g/well) and C (5, 10, 25, 50 and 100 g/well)
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por  22 h. DEX (10 mol/L) and LPS (5 g/mL) were used as negative and positive con
rom  LPS (P < 0.001); ***signiﬁcantly different from LPS (B) (P < 0.0001). Data are exp
hereas 100 g/well inhibited its production (P < 0.001) (Fig. 2A).
itral (5, 10, 25, 50 and 100 g/well) decreased (P < 0.0001) IL-6
roduction by macrophages (Fig. 2A).
The inhibitory concentrations of Cymbopogon citratus
100 g/well) and citral (5, 10, 25, 50 and 100 g/well) were
nalyzed in the next protocol. Fig. 2B shows that Cymbopogon
itratus showed inhibitory effects only after LPS challenge, and IL-6
roduction was lower than that induced by LPS alone (P < 0.0001).
itral prevented efﬁciently LPS effects before and after LPS addition
P < 0.0001) at all concentrations (Fig. 2B).
.2.3. IL-10 production
There were no signiﬁcant differences in IL-10 production by
acrophages treated with LG (P > 0.05), whereas citral (25, 50 and
00 g/well) inhibited its release (P < 0.01) (Fig. 3A).
Although lemongrass did not inhibit IL-10 production, the con-
entration of 100 g/well was tested in the LPS-challenge protocol,
ecause it inhibited IL-6 production. In fact, one may  verify in Fig. 3B
hat LG (100 g/well) inhibited signiﬁcantly LPS action (P < 0.001),
fter macrophages incubation with LPS. Citral (5, 10, 25, 50 and
00 g/well) counteracted signiﬁcantly LPS action when added
efore or after LPS incubation (P < 0.0001) except when cells were
ncubated with citral (5 g/well) and subsequently challenged with
PS (P > 0.05) when compared to LPS alone (Fig. 3B).
In all assays, DEX and LPS exerted their inhibitory and stim-
latory activities, as negative and positive controls of cytokine
roduction, respectively.espectively. *Signiﬁcantly different from control (P < 0.01); **signiﬁcantly different
d as means ± standard-deviation of 5–7 similar assays.
4. Discussion
Immunomodulators may  be deﬁned as agents that affect the
immune system by regulating molecules, such as cytokines, hor-
mones, neurotransmitters and others peptides, stimulating or
inhibiting the events of the immune response (Spelman et al.,
2006). In this study, we investigated the immunomodulatory action
of Cymbopogon citratus and citral on cytokines production.
Previous works from our laboratory revealed that the treatment
of mice with LG water extract inhibited macrophages to produce
IL-1 and IL-6. LG essential oil inhibited these cytokines produc-
tion by macrophages in vitro as well (Sforcin et al., 2009). These
data encouraged us to investigate the effects of LG before and after
macrophages challenge with LPS, in order to evaluate its efﬁcacy as
a possible anti-inﬂammatory agent, since there is a traditional use
of LG for different purposes.
The chemical composition of Cymbopogon citratus (extract and
essential oil) was previously described (Sforcin et al., 2009), and
citral and linalool were the major constituents of our sample. Thus,
we also evaluated citral effects in our assays, in order to investigate
a possible involvement of this compound in Cymbopogon citratus
action.
Lemongrass stimulated IL-1 production, whereas citral stim-
ulated and inhibited its production depending on concentration.
In our study, we  included LPS-challenge protocols in order to
observe a possible preventive or therapeutic action. Citral was more
efﬁcient to inhibit IL-1 production when incubated before LPS
addition to the cells, suggesting its preventive activity.
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LG stimulated and inhibited IL-6 production by macrophages,
epending on concentration, while citral inhibited IL-6 release. In
PS protocols, LG was more efﬁcient when added after LPS incuba-
ion, whereas citral seemed to be efﬁcient either before or after LPS
ddition.
LG and citral inhibited IL-10 production. In LPS protocols, LG
xerted a therapeutic action by counteracting LPS stimulatory
ction, while citral showed preventive and therapeutic effects.
Figueirinha et al. (2010) demonstrated that Cymbopogon citratus
eaf infusion signiﬁcantly inhibited other inﬂammatory param-
ters: nitric oxide (NO) production and inducible NO synthase
xpression by LPS-stimulated mouse skin dendritic cells, suggest-
ng its anti-inﬂammatory activity. The pharmacological properties
f citral were also investigated (Lertsatitthanakorn et al., 2006).
egarding its anti-inﬂammatory effects, Lee et al. (2007) reported
hat citral blocked LPS-induced activation of NF-B by inhibiting
he phosphorylation of IB, which in turn inhibited p65 and p50
ranslocation to the nucleus – an initial process for gene expression
f several cytokines. Anti-inﬂammatory effects of several natural
roducts such as Butea monosperma and Marasmius oreades and
heir compounds gallatanins, butin, isobutin and butein have been
eported to inhibit NF-B activation (Lee et al., 2007; Rasheed et al.,
010), suggesting that the transcription factor NF-B is an obvious
arget of anti-inﬂammatory therapeutics (Gadjeva et al., 2010).
Taken together, our data are in agreement with those found in
iterature, pointing out to the anti-inﬂammatory effects of citral,
hich may  be involved in LG inhibitory effects on cytokines pro-
uction, and a possible mechanism involved in LG and citral actions
ould be the inhibition of the transcription factor NF-B. However,
ne should take into account that other chemical constituents in LG
xtract may  affect cytokine production; moreover, herein we  did
ot intend to compare the activities of citral and lemongrass, since
itral concentration in the extract may  be different from that of
solated citral used in our assays in vitro. Since inﬂammation plays
n important role in host homeostasis, immunomodulatory agents
ay  be useful to maintain or restore this balance. The potential of
oth LG and citral as immunomodulatory and anti-inﬂammatory
gents should be further explored, in order to understand under
hich conditions they might be useful tools for prevention or treat-
ent of inﬂammatory diseases.
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